Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Cancer Therapies02:49

Cancer Therapies

9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Metastasis02:30

Metastasis

6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

Cancer research·2026
Same author

Defining the dystrophic femoral neck in osteogenesis imperfecta: a radiographic and anatomical entity with diagnostic threshold.

SICOT-J·2026
Same author

Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

JCO precision oncology·2026
Same author

Safety and outcome of transscleral fine-needle aspiration biopsy in uveal melanoma: 10-year experience in 347 cases.

Retina (Philadelphia, Pa.)·2026
Same author

ASO Author Reflections: The Role of Neoadjuvant Chemotherapy in the Management of Primary Retroperitoneal Germ Cell Tumors in Children.

Annals of surgical oncology·2026
Same author

Challenges in Managing Primary Retroperitoneal Germ Cell Tumors in Children: The Role of Neoadjuvant Chemotherapy.

Annals of surgical oncology·2026

相关实验视频

Updated: Jan 17, 2026

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

12.9K

[欧文肉瘤目前的治疗方法:有什么新鲜事?]

Sarah Winter1, Gaelle Pierron2, Sylvie Helfre3

  • 1Institut Curie, centre intégré de soins et de recherche en oncologie de l'enfant, adolescent et jeune adulte (SIREDO), Paris, France.

Bulletin du cancer
|January 14, 2026
PubMed
概括

尤文肉瘤 (ES) 是年轻人面临的一个具有挑战性的癌症. 针对特定分子途径的新型疗法和免疫疗法在转移性或复发性疾病患者的改善结果方面表现有前途.

关键词:
生物标志物 生物标志物生物标志物 生物标志物尤文肉瘤 (Ewing Sarcoma) 是一种癌症.免疫治疗是一种免疫疗法.免疫疗法是一种免疫疗法.萨尔科姆·德温格 (Sarcome d'Ewing) 是一个著名的作家.有针对性的治疗方法.有针对性的治疗方法.

更多相关视频

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.2K
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

12.2K

相关实验视频

Last Updated: Jan 17, 2026

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

12.9K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.2K
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

12.2K

科学领域:

  • 儿科瘤学 儿科瘤学
  • 肉瘤研究研究 肉瘤研究
  • 分子生物学分子生物学

背景情况:

  • 尤文肉瘤 (ES) 是一种侵袭性骨和软组织癌症,主要影响青少年和年轻人.
  • 目前的结合化疗和局部疗法的治疗方案对转移性或复发性疾病的患者提供有限的成功,这些患者的预后不好.

研究的目的:

  • 审查最近在尤文瘤生物学和治疗策略方面的进展.
  • 突出新的分子标和Ewing肉瘤的新兴治疗方式.

主要方法:

  • 关于尤文肉瘤病原和治疗的当前文献的综述.
  • 对新型治疗剂的临床前和临床数据的分析.
  • 讨论免疫治疗方法和生物标志物开发.

主要成果:

  • 对ES生物学有了更好的理解,揭示了几个有前途的治疗点.
  • 铁氨酸激酶抑制剂,EWSR1:FLI1向剂,细胞周期/细胞亡/DNA修复途径调节剂正在研究中.
  • 化学抗原受体 (CAR) -T和CAR-NK细胞疗法代表了新兴的免疫治疗策略.

结论:

  • 新型向疗法和免疫疗法具有显著的潜力,可以改善尤宁肉瘤治疗结果.
  • 对生物标志物的前性验证对于未来将其纳入标准临床护理至关重要.
  • 临床医生和生物学家之间的持续合作对于推进尤文肉瘤研究至关重要.